Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The epidemiology of ALS and the role of population-based registries.

Literature DB >> 17071060

The epidemiology of ALS and the role of population-based registries.

Ettore Beghi¹, Giancarlo Logroscino, Adriano Chiò, Orla Hardiman, Douglas Mitchell, Robert Swingler, Bryan J Traynor.

Abstract

Entities: Disease

Mesh：

Year: 2006 PMID： 17071060 DOI： 10.1016/j.bbadis.2006.09.008

Source DB: PubMed Journal: Biochim Biophys Acta ISSN： 0006-3002

Keyword Cloud
Cited

× No keyword cloud information.

64 in total

1. Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.

Authors: Philippe Corcia; Caroline Ingre; Helene Blasco; Rayomand Press; Julien Praline; Catherine Antar; Charlotte Veyrat-Durebex; Yves-Olivier Guettard; William Camu; Peter M Andersen; Patrick Vourc'h; Christian R Andres
Journal: Eur J Hum Genet Date: 2012-01-25 Impact factor: 4.246

Review 2. Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Authors: Barrie J Carter; Pervin Anklesaria; Stephanie Choi; John F Engelhardt
Journal: Antioxid Redox Signal Date: 2009-07 Impact factor: 8.401

3. Genome-wide association studies in amyotrophic lateral sclerosis.

Authors: Nicolas Dupré; Paul Valdmanis
Journal: Eur J Hum Genet Date: 2008-11-05 Impact factor: 4.246

4. Automatic prediction of intelligible speaking rate for individuals with ALS from speech acoustic and articulatory samples.

Authors: Jun Wang; Prasanna V Kothalkar; Myungjong Kim; Andrea Bandini; Beiming Cao; Yana Yunusova; Thomas F Campbell; Daragh Heitzman; Jordan R Green
Journal: Int J Speech Lang Pathol Date: 2018-11-08 Impact factor: 2.484

The epidemiology of ALS and the role of population-based registries.

1. Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.

Review 2. Redox modifier genes and pathways in amyotrophic lateral sclerosis.

3. Genome-wide association studies in amyotrophic lateral sclerosis.

4. Automatic prediction of intelligible speaking rate for individuals with ALS from speech acoustic and articulatory samples.

5. Changing epidemiology of motor neurone disease in Scotland.

6. Time-trend evolution and determinants of sex ratio in Amyotrophic Lateral Sclerosis: a dose-response meta-analysis.

7. [Simultaneous presentation of amyotrophic lateral sclerosis and multiple sclerosis].

8. Screening for replication of genome-wide SNP associations in sporadic ALS.

9. An estimate of amyotrophic lateral sclerosis heritability using twin data.

10. Latent cluster analysis of ALS phenotypes identifies prognostically differing groups.